Recruiting studies: Gram Negative Bacteremia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · 50 location(s) · Infectopharm Arzneimittel GmbH · NCT02979951 Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
NA · 1 location(s) · Valeria Cento · NCT07372131 Early Oral Switch for Uncomplicated Gram-negative Bacteraemia
Phase 4 · 1 location(s) · Tan Tock Seng Hospital · NCT05199324 Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223 Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
Phase 4 · 13 location(s) · Thomas Benfield · NCT04291768 A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Pat
Phase N/A · 1 location(s) · TTY Biopharm · NCT06966284 A Platform Trial for Gram Negative Bloodstream Infections
NA · 39 location(s) · Sunnybrook Health Sciences Centre · NCT06537609 Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial B
Phase 2 · 2 location(s) · Gamaleya Research Institute of Epidemiology and Microbiology · NCT06135350 The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
NA · 1 location(s) · Istituto Clinico Humanitas · NCT07491419 PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enter
Phase 4 · 14 location(s) · Rambam Health Care Campus · NCT03671967 Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
NA · 11 location(s) · Johns Hopkins University · NCT06080698

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.